Quantcast

Latest Novartis Stories

2014-09-30 08:31:42

WOODCLIFF LAKE, N.J., Sept. 30, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the generic version of Novartis' Exforge(®). Par received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for amlodipine and valsartan and was granted 180 days of marketing exclusivity. Amlodipine and valsartan is indicated for the treatment of...

2014-09-29 00:20:31

BASEL, Switzerland, Sept. 29, 2014 /PRNewswire/ -- Syngenta today announced that John Atkin, Chief Operating Officer, will retire from the company at the end of 2014. He will be succeeded by Jon Parr, who will assume responsibility for two of the company's four regions: Europe, Africa and the Middle East and Latin America. North America and Asia Pacific will remain under the leadership of Davor Pisk, Chief Operating Officer. Jon Parr has worked for Syngenta and its legacy companies...

2014-09-27 08:21:23

- Afinitor led to an unprecedented median overall survival of 44 months, which represents a clinically meaningful while not statistically significant improvement(1) EAST HANOVER, N.J., Sept. 27, 2014 /PRNewswire/ -- Novartis today presented final results on overall survival (OS) from a Phase III trial of Afinitor(®) (everolimus) tablets plus best supportive care (BSC) compared to placebo plus BSC in patients with well-differentiated advanced and progressive pancreatic...

2014-09-25 23:05:01

A recent breakthrough in clinical results with an experimental drug to treat heart failure has shown very promising results. There has not been a breakthrough of this magnitude in cardiovascular in nearly an entire decade. NAPSRx will continue to monitor and update its nearly 87,000 pharmaceutical sales rep members over the next few months. Updates have also been added to the CNPR Certification program. Chicago, IL (PRWEB) September 25, 2014 An investigational medicine, LCZ696 was...

2014-09-25 12:29:32

DUBLIN, Sept. 25, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered look at the pharmaceutical industry,...

2014-09-22 23:02:42

New research report “Global Cancer Vaccines Market & Pipeline Analysis” worked out by Kuick Research is now available at MarketPublishers.com. London, UK (PRWEB) September 22, 2014 The R&D of cancer vaccines has seen a considerable growth in the recent years. The statistically important data received from clinical research studies have confirmed the efficacy and safety of cancer vaccines. The primary challenge to the development of such vaccines is the lack of sufficient...

2014-09-19 00:21:26

BASEL, Switzerland, Sept. 19, 2014 /PRNewswire/ -- -- Global network of over 3,500 farms established to measure productivity -- First independently-audited data to be published in March 2015 -- Projects underway in all regions; partnerships agreed and expanded Syngenta today provided an update on the progress of The Good Growth Plan one year after its launch in September 2013. The Plan comprises six measurable commitments for the year 2020 to help address the global food...

2014-09-12 16:24:47

WASHINGTON, Sept. 12, 2014 /PRNewswire/ -- Syngenta today responded to the lawsuit filed against Syngenta Seeds, Inc. in Louisiana state court by Cargill. Syngenta believes that the lawsuit is without merit and strongly upholds the right of growers to have access to approved new technologies that can increase both their productivity and their profitability. The Agrisure Viptera(®) trait (MIR162) was approved for cultivation in the U.S. in 2010. Syngenta commercialized the trait...

2014-09-12 16:23:36

DUBLIN, Sept. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Diclofenac Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The Global Diclofenac Industry Report 2014 is a professional and in-depth study on the current state of the global diclofenac industry . The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The...

2014-09-12 12:22:13

- "Right to Grow" program offers U.S. farmers corn rootworm control and a stewardship premium for Agrisure Duracade corn planted in 2015 MINNETONKA, Minn., Sept. 12, 2014 /PRNewswire/ -- Syngenta announced today that it has renewed and enhanced its program with Gavilon Grain, LLC, to provide grain marketing opportunities for U.S. farmers who plant Agrisure Duracade(TM) in 2015. Agrisure Duracade is Syngenta's cutting-edge corn rootworm (CRW) control technology approved in the U.S....


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related